Target intelligence / Profile preview

Monosialotetrahexosylganglioside GM1 receptor (GM1)

Target
GM1
Molecular classification
Receptor, Glycolipid, Ganglioside
01

Overview

The GM1 ganglioside—formally known as monosialotetrahexosylganglioside GM1—is a glycosphingolipid present on the surface of mammalian cells, including the small intestinal epithelial cells. It serves as the canonical receptor for the enterotoxigenic Escherichia coli (ETEC) heat-labile toxin, as well as cholera toxin, by binding the toxin’s B subunit and facilitating its entry into the host cell[4]. This interaction triggers signaling cascades that ultimately lead to the secretory diarrhea characteristic of ETEC infections[2][4]. GM1’s role as a toxin receptor makes it an attractive but challenging therapeutic target, with most strategies focusing on inhibiting toxin binding or enhancing host immunity rather than directly modulating GM1 itself[2][4].

Other names
GM1 gangliosideGM1Monosialotetrahexosylganglioside
02

Mechanism of action

Drugs or molecules that prevent ETEC heat-labile toxin or cholera toxin from binding GM1 can block toxin-induced diarrhea Mechanistic vaccines or neutralizing antibodies act by interruption of toxin-receptor interaction

03

Biological functions

Functions as a cell-surface receptor for the ETEC heat-labile toxinMediates toxin binding and entry into small intestinal epithelial cellsParticipates in lipid raft organization at the cell membrane
04

Disease associations

Infection (diarrheal disease caused by enterotoxigenic E. coli)Other bacterial toxin-related pathologies
05

Safety considerations

Disrupting GM1 function broadly could affect neuronal and membrane processes, as GM1 is involved in neurobiology and cell signalingTherapeutic approaches to block GM1 binding must be tissue-specific to avoid systemic effects
06

Interacting drugs

No approved drugs directly targeting GM1 to block ETEC, but experimental approaches include inhibitors of toxin binding

1 more in the full profile.

07

Biomarkers

GM1 expression in intestinal epithelial tissue can be used experimentally to identify susceptibility to enterotoxin binding

Beyond the preview

Go deeper on Monosialotetrahexosylganglioside GM1 receptor (GM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monosialotetrahexosylganglioside GM1 receptor (GM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call